Cipla appoints Shivam Puri as CEO – One India Business from July 1, 2026

Management Changes View source PDF Explain this filing

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹1380.60

prior close

₹1368.60

announcement price

In-mkt

timing

Nifty 100market+0.5%-0.9% vs market

Pharmaceuticals peers, median of 164sector-0.2%-0.2% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty 100 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.1

15m

+0.2

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4+0.5-0.9-0.2-0.2

Next day

-2.2+0.9-3.1-0.3-2.0

-1.6+1.3-2.9+0.6-2.2

-2.0+0.7-2.7+0.6-2.6

+2.6+1.2+1.4+1.4+1.3

+3.9-0.0+3.9+1.7+2.3

+4.2+0.8+3.4+1.2+3.1

15d

+3.5-0.1+3.6+2.2+1.4

+3.6+0.8+2.8+4.8-1.2

+3.7+2.2+1.5+2.7+1.0

-1.6-2.5+0.9+6.6-8.3

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cipla's board approved the appointment of Mr Shivam Puri as CEO – One India Business and a member of the Management Council, designated as Senior Management Personnel, effective July 1, 2026. Puri is currently MD & CEO of Cipla Health Ltd, the company's wholly owned consumer healthcare subsidiary, a role he has held since 2019. He brings 23+ years of experience across FMCG and healthcare, including senior roles at Hindustan Unilever, Jubilant FoodWorks, and ITC. He holds a B.Tech from IIT Varanasi and an MBA from IIM Lucknow. The board also approved stock options (11,360 at ₹2) and 51,394 ESARs under existing employee schemes.

Likely market impact

Internal leadership elevation; no governance concerns. Signals continuity from Cipla's consumer health arm into core India operations.